Literature DB >> 7744876

Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin.

C I Wang1, Q Yang, C S Craik.   

Abstract

Ecotin, a serine protease inhibitor found in the periplasm of Escherichia coli, is unique in its ability and mechanism of inhibiting serine proteases of a broad range of substrate specificity. However, although the catalytic domain of human urokinase-type plasminogen activator (uPA) has 40% identity to bovine trypsin and the substrate specificities of these two proteases are virtually identical, ecotin inhibits uPA almost 10,000-fold less efficiently than trypsin. Ecotin was expressed on the surface of filamentous bacteriophage (ecotin phage) to allow the isolation of more potent inhibitors of uPA from a library of ecotin variants. The 142-amino acid inhibitor was fused to the C-terminal domain of the M13 minor coat protein, pIII, through a Gly-Gly-Gly linker and assembled into phage particles. The ecotin phage were shown to react with anti-ecotin antibodies, revealing a stoichiometry of approximately one ecotin per bacteriophage. The ecotin displayed on the surface of phage inhibited trypsin with an equilibrium dissociation constant of 6.7 nM, in close approximation to that of free ecotin, indicating that phage-associated ecotin is correctly folded and functionally active. Reactive-site amino acids 84 and 85 of ecotin were then randomized and a library of 400 unique ecotin phage was created. Three hundred thousand members of the library were screened with immobilized uPA and subjected to three rounds of binding and in vitro selection. DNA sequence analysis of the selected ecotin phage showed that ecotin M84R/M85R predominated while ecotin M84R, M84K, and M84R/M85K were present at a lower frequency. The four ecotin variants were overexpressed and purified and their affinities toward uPA were determined. Each of the selected ecotin variants exhibited increased affinity for uPA when compared to wild-type ecotin with ecotin M84R/M85R showing a 2800-fold increase in binding affinity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744876     DOI: 10.1074/jbc.270.20.12250

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Authors:  Daniel Legendre; Bénédicte Vucic; Vincent Hougardy; Anne-Lise Girboux; Christophe Henrioul; Julien Van Haute; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires.

Authors:  N Dimasi; F Martin; C Volpari; M Brunetti; G Biasiol; S Altamura; R Cortese; R De Francesco; C Steinkühler; M Sollazzo
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  Phage-displayed peptide libraries.

Authors:  M B Zwick; J Shen; J K Scott
Journal:  Curr Opin Biotechnol       Date:  1998-08       Impact factor: 9.740

Review 4.  In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

Authors:  J Fastrez
Journal:  Mol Biotechnol       Date:  1997-02       Impact factor: 2.695

5.  A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Authors:  S Selvarajan; L R Lund; T Takeuchi; C S Craik; Z Werb
Journal:  Nat Cell Biol       Date:  2001-03       Impact factor: 28.824

6.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue.

Authors:  T Takeuchi; M A Shuman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Novel inter-protein cross-link identified in the GGH-ecotin D137Y dimer.

Authors:  M D Person; K C Brown; S Mahrus; C S Craik; A L Burlingame
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

Review 8.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

9.  The mechanism of inhibition of antibody-based inhibitors of membrane-type serine protease 1 (MT-SP1).

Authors:  Christopher J Farady; Jeonghoon Sun; Molly R Darragh; Susan M Miller; Charles S Craik
Journal:  J Mol Biol       Date:  2007-04-04       Impact factor: 5.469

10.  Improving Cry8Ka toxin activity towards the cotton boll weevil (Anthonomus grandis).

Authors:  Gustavo R Oliveira; Maria C M Silva; Wagner A Lucena; Erich Y T Nakasu; Alexandre A P Firmino; Magda A Beneventi; Djair S L Souza; José E Gomes; José D A de Souza; Daniel J Rigden; Hudson B Ramos; Carlos R Soccol; Maria F Grossi-de-Sa
Journal:  BMC Biotechnol       Date:  2011-09-09       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.